Companies
STOXX 600Health Care· Switzerland
LONN
Status-Quo-PlayerLonza Group
$533.80
+0.91%
Open $530.00·Prev $529.00
Delayed
STATUS-QUO-PLAYER
Power Core
Lonza's moat is regulatory-validated manufacturing capacity for complex biologics, where switching costs compound over the lifetime of each drug product.
Published15 Apr 2026
UniverseSTOXX 600
SectorHealth Care
↑
Direction of Movement
upward
News
No recent news available.
mOS zones are proprietary L17X overlays and do not constitute trading signals or investment advice.